Monographs

This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.

Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.

Search

Starting with 'LY'

Title Information Source Document Type  
LYCLEAR Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LYCLEAR Creme rinse Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LYFNUA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
LYMPHOSEEK Kit for radiopharmaceutical preparation European Medicines Agency (EU) MPI, EU: SmPC
LYNLOR Capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LYNPARZA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
LYNPARZA Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
LYRICA Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
LYRINEL XL Prolonged release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LYSAKARE Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
LYSODREN Tablet European Medicines Agency (EU) MPI, EU: SmPC
LYTENAVA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
LYTGOBI Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
LYUMJEV Solution for injection European Medicines Agency (EU) MPI, EU: SmPC
LYXUMIA Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.